Related references
Note: Only part of the references are listed.Perceptions from pharmaceutical stakeholders on how the pharmaceutical budget is allocated in South Africa
Lirosha Moodley et al.
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE (2021)
Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
Phyllis Ocran Mattila et al.
FRONTIERS IN PUBLIC HEALTH (2021)
Registration and local production of essential medicines in Uganda
Petra Brhlikova et al.
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE (2020)
Access to WHO Essential Medicines for Childhood Cancer Care in Trinidad and Tobago: A Health System Analysis of Barriers and Enablers
Brandon Tang et al.
JCO GLOBAL ONCOLOGY (2020)
Acceptability and feasibility of a national essential medicines list in Canada: a qualitative study of perceptions of decision-makers and policy stakeholders
Jordan D. Jarvis et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2019)
Use of evidence and negotiation in the review of national standard treatment guidelines and essential medicines list: experience from Ghana
Augustina Koduah et al.
HEALTH POLICY AND PLANNING (2019)
Essential medicines availability is still suboptimal in many countries: a scoping review
Mersiha Mahmic-Kaknjo et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases
Sandeep P. Kishore et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Andrea C. Tricco et al.
ANNALS OF INTERNAL MEDICINE (2018)
Essential medicines for universal health coverage
Veronika J. Wirtz et al.
LANCET (2017)
Essential Medicines List Implementation Dynamics: A Case Study Using Brazilian Federal Medicines Expenditures
Rachel Magarinos-Torres et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Velisha Ann Perumal-Pillay et al.
BMC HEALTH SERVICES RESEARCH (2017)
Essential psychiatric medicines: wrong selection, high consumption and social problems
Izabela Fulone et al.
BMC PUBLIC HEALTH (2016)
Evaluation of the implementation outcomes of the Essential Medicines System in Anhui county-level public hospitals: a before-and-after study
Shuman Xu et al.
BMC HEALTH SERVICES RESEARCH (2015)
Tough decisions on essential medicines in 2015
Nicola Magrini et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2015)
Overcoming Obstacles To Enable Access To Medicines For Noncommunicable Diseases In Poor Countries
Sandeep P. Kishore et al.
HEALTH AFFAIRS (2015)
Medicines for cancers in children: The WHO model for selection of essential medicines
Jane Robertson et al.
PEDIATRIC BLOOD & CANCER (2015)
Civil Society Organizations and medicines policy change: A case study of registration, procurement, distribution and use of misoprostol in Uganda
Esther Cathyln Atukunda et al.
SOCIAL SCIENCE & MEDICINE (2015)
Using Qualitative Evidence in Decision Making for Health and Social Interventions: An Approach to Assess Confidence in Findings from Qualitative Evidence Syntheses (GRADE-CERQual)
Simon Lewin et al.
PLOS MEDICINE (2015)
Essential Medicines in a High Income Country: Essential to Whom?
Mai Duong et al.
PLOS ONE (2015)
Does Economic Incentive Matter for Rational Use of Medicine? China's Experience from the Essential Medicines Program
Mingsheng Chen et al.
PHARMACOECONOMICS (2014)
Decisions on WHO's essential medicines need more scrutiny
Corrado Barbui et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Access to Essential Medicines in Pakistan: Policy and Health Systems Research Concerns
Shehla Zaidi et al.
PLOS ONE (2013)
Does perverse economic incentive lead to the irrational uses of medicines?
Wenhui Mao et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2013)
Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
A. Cameron et al.
LANCET (2009)
The concept of essential medicines: lessons for rich countries
HV Hogerzeil
BRITISH MEDICAL JOURNAL (2004)
25 years of the WHO essential medicines lists: progress and challenges
R Laing et al.
LANCET (2003)
Time for a revival? Public policy implementation: a review of the literature and an agenda for future research
J Schofield
INTERNATIONAL JOURNAL OF MANAGEMENT REVIEWS (2001)
Share Paper
